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Maintaining high levels of adherence to therapy modalities is essential to ensure that a 
therapy is being delivered as prescribed. The current study evaluated therapist adherence to 
cognitive behavioural therapy (CBT) and schema therapy modalities in the treatment of 
depression. Therapy sessions from 99 participants were rated using the Collaborative Study 
Psychotherapy Rating Scale for the Comparison of Cognitive Therapies (CSPRS-CCT). 
Three sessions were selected for each participant from early, middle and late phases of 
therapy. It was hypothesised that therapy sessions of participants randomised to CBT would 
have higher adherence scores on the CBT subscale than those randomised to schema therapy 
and therapy sessions of those randomised to schema therapy would have higher adherence 
scores on the schema therapy subscale than those randomised to CBT. Scores on the 
facilitative conditions and explicit directiveness subscales of the CSPRS-CCT were expected 
to be similar across therapy type. Adherence was expected to be rated higher in the early to 
middle phases of treatment and to stabilise or decrease in the later stage of therapy, for both 
therapy groups. The CBT group was found to score higher on the CBT subscale, while the 
schema therapy group scored higher on the schema therapy subscale. No difference was 
found between the two therapies on the facilitative conditions and explicit directiveness 
subscales. A therapy by phase interaction was found for the CBT subscale with the schema 
therapy group’s scores increasing slightly over the three phases of therapy, while scores for 
the CBT group decreased over therapy. No therapy by phase interaction was found for the 
schema therapy subscale.. Understanding how therapies are delivered is an important step 
in determining what aspects play a role in effective therapy. Having reliable ways to assess 
delivery of these therapies allows us to determine if a psychotherapy is being delivered to a 





Depression affects over 300 million people worldwide (World Health Organization, 
2017). In the American Psychiatric Association’s DSM-5 (2013), depressive disorders are 
characterised by sadness, emptiness, or irritability and the individual’s capacity to function 
is affected by somatic and/or cognitive changes. The Annual Update of Key Results 
2015/16: New Zealand Health Survey (Ministry of Health, 2016) reported 6.8% of adults 
had experienced psychological distress within the past four weeks. This equates with 
around 256,000 New Zealand adults experiencing psychological distress, including 
depression, at any one time. Te Rau Hinengaro: The New Zealand Mental Health Survey 
reported the projected lifetime risk of major depressive disorder by age 75 to be 25.7%, 
indicating that around one quarter of New Zealanders will experience major depressive 
disorder at some point in their lives (Oakley-Browne et al., 2006).  
Depression can have a profound impact on the physical, emotional and spiritual 
wellbeing of people experiencing it. The Royal Australian and New Zealand College of 
Psychiatrists (2016) estimated that the Disability-Adjusted Life Years (DALY) for severe 
depression in New Zealand is 20,414, based on Global Burden of Disease data from 2010. 
DALY is the sum of the years which have been lost due to premature mortality and 
disability caused by an illness. According to this same report, people who access the 
mental health system in NZ have more than twice the mortality rate of the general 
population.  
Treatment for depression 
Due to the high prevalence and significant burden of depression, effective 
treatments are vital. Psychotherapies and medications are currently the main treatments for 
depression, with psychotherapies being the preferable treatment for mild to moderate 
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depression (Malhi et al., 2018). DeRubeis et al. (2005) found similar effectiveness of 
cognitive therapies and antidepressants for treating those with moderate to severe 
depression. Boschloo et al. (2019) compared treatment of depression with cognitive 
behavioural therapy (CBT) versus antidepressants. Overall they found a slightly larger 
improvement for those treated with antidepressants However when they examined the  
individual symptoms of depression using the Hamilton Depression Rating Scale they found 
that, while five depressive symptoms responded better to treatment with antidepressants 
than to treatment with CBT, no difference was found between antidepressants and CBT for 
the other 12 symptoms. While antidepressants are commonly prescribed as a treatment for 
depression, they come with a higher risk of relapse, particularly in those who have 
recovered and then discontinue antidepressant use (DeRubeis et al., 2008; Berwian et al., 
2017). Antidepressants can also come with side-effects, and several may need to be tried 
before a suitable type is found (Berwian et al. 2017).  
Because psychotherapies are a key treatment in depression, it is important to ensure 
therapists are using them correctly so they have the intended impact on clients. Cognitive 
behavioural therapies are a type of psychotherapy, defined as a time-limited structured 
approach to treating various psychiatric disorders (Beck et al., 1979). Cognitive 
behavioural therapy and schema therapy are two such cognitive psychotherapies used in 
the treatment of depression. Cognitive behavioural therapy focuses on assisting clients to 
change problematic patterns in thinking and behaviour, which are occurring in the present 
(Beck et al., 1979; Beck, 1995). Schema therapy was originally developed to treat 
personality disorders targeting maladaptive schemas, and unmet emotional needs, which 
have developed early in the individual’s life (Young, 1990), and is now also used in the 
treatment of Axis I disorders  (DSM-IV; American Psychiatric Association, 2000) such as 
depression.  
 CBT and schema therapy have therapy-specific and overlapping components. CBT 
specific components include recording and monitoring thoughts, recognising cognitive 
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errors and understanding the relationship between thoughts and feelings. Schema therapy 
includes components such as understanding the activation of schemas and modes, linking 
development of these schemas and modes to early life and to depressive symptoms using 
experiential strategies to heal schemas and strengthening healthy schemas and modes. Both 
CBT and schema therapy have overlapping components such as education about 
depression, addressing the need for change, and collaborative aspects such as reviewing 
progress and negotiation of therapy content, while encouraging the client’s independence.  
Therapist adherence and outcome 
Research about treatment adherence aims to determine that a therapy is being 
delivered as it was intended, according to established treatment guidelines and protocols 
(Hogue et al., 1996). If treatment adherence is high, it can be concluded that the particular 
treatment modality is being delivered as intended. Adherence research is important in 
psychotherapy research. It is essential to understand the mechanisms of change in 
psychotherapies such as cognitive behavioural therapy and schema therapy and to 
understand how the benefits of therapies can be maximised. 
Substance abuse was the focus for Martino et al. (2008), who used the Independent 
Tape Rater Scale to rate therapist adherence to motivational enhancement therapy, a 
variant of motivational interviewing, for the outpatient treatment of substance use 
problems.  Higher levels of therapist competence (how skilfully the therapist delivers 
therapeutic techniques) and adherence to motivational enhancement therapy for drug abuse 
were found to be associated with increased client motivation and some positive treatment 
outcomes such as increased negative drug screens.  
Greater adherence at early and middle stages of enhanced CBT (CBT-E) has been 
found to be associated with better outcome for bulimia nervosa, in a study involving 36 
adult participants (Folke et al., 2017). Adherence to cognitive therapy techniques has been 
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found to be associated with greater symptom improvement for those with more severe 
symptoms of depression by Webb et al. (2012) involving 105 adult participants with major 
depression.  
Hogue et al. (2008) conducted a study involving 136 adolescents with substance 
abuse and related behaviour problems (internalising and externalising behaviours). 
Stronger adherence to CBT, but not to multidimensional family therapy predicted a greater 
reduction in cannabis use. Stronger adherence to both therapies predicted a greater 
reduction in externalising symptoms, and intermediate adherence to both therapies 
predicted a greater reduction in internalising problems.  
Goldman and Gregory (2009) examined adherence as a predictor of outcome in 
dynamic deconstructive therapy (DDP) for ten people with borderline personality disorder 
and alcohol problems. Adherence was assessed using a 25 item scale, 16 items of which 
assessed adherence to the DDP model, while the other nine items assessed interventions 
which were contraindicated in the DDP model. Adherence was positively associated with 
improvement in primary symptom severity, and in all secondary symptom measures 
(parasuicidal behaviour, heavy drinking, institutional care, depression and dissociation) 
with the exception of perceived social support. 
Multisystemic therapy was used to treat 1979 youths with antisocial behavioural 
problems in a study by Chapman and Schoenwald (2011). Adherence predicted greater 
reductions in both internalising and externalising problems, and was associated with lower 
post-treatment criminal activity. Lange et al. (2017) studied therapist adherence to MST for 
externalising behaviour problems in 4290 Dutch adolescents. Therapist adherence was 
found to predict all three post-treatment outcome measures – living at home, engagement 
in school or work, and no new arrests. Therapist experience and language but not client 
gender were found to be predictors of therapist adherence.  
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Lange et al. (2019) investigated parental perceptions of therapist adherence in 848 
families receiving multisystemic therapy (MST) for antisocial adolescent behaviour and 
found that adherence did not predict outcome after controlling for therapist/client alliance.  
Therapist adherence to CBT for people with panic disorder was studied by Huppert 
et al. (2006), who found that higher pre-treatment Anxiety Sensitivity Index (ASI; Peterson 
& Reiss, 1992) scores were related to greater adherence, particularly in earlier therapy 
sessions. Adherence alone was not significantly related to change on the ASI or Panic 
Disorder Severity Scale (PDSS; Shear et al., 1997), but was found to interact with 
motivation to predict outcome on the PDSS, but not on the ASI. 
Barber et al. (1996) found that adherence to techniques in supportive expressive 
psychodynamic therapy did not predict change in depression. Barber et al.’s study involved 
the rating of audiotapes of session three for 29 clients with major depression using the 
Penn Adherence-Competence Scale for Supportive-Expressive therapy (Barber & Crits-
Christoph, 1996). Webb et al. (2010) conducted a meta-analysis of 36 studies examining 
the relationship between adherence or competence and outcome. Therapies examined in 
the 36 studies were interpersonal psychotherapy (IPT), CBT, dynamic therapy and emotion 
focused trauma therapy for depression, drug use, mixed diagnoses, bulimia and child abuse 
trauma. No association was found between therapist adherence and outcome. Weck et al. 
(2013) found that adherence was not associated with decreased relapse one year after 
treatment with maintenance CBT for recurrent major depression. Campos-Malady et al. 
(2017) found that while adherence to the adolescent community reinforcement approach, a 
behavioural intervention for youth substance use, that includes the wider family and other 
social and environmental reinforcers, was not predictive of substance use outcome for the 
entire sample of adolescent participants, adherence did predict decreased substance use in 
those who completed the 12 month follow-up. A 2018 study by Snippe et al. measured 
therapist adherence by rating the occurrence or non-occurrence of techniques from the 
CBT and mindfulness-based cognitive therapy manuals, and found that therapist adherence 
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to CBT and mindfulness-based cognitive therapy was not predictive of post-treatment 
depressive symptoms in people with diabetes. 
Measurement of adherence  
The Collaborative Study Psychotherapy Rating Scale (CSPRS) was developed to 
rate therapist adherence to CBT, IPT and clinical management in the treatment of 
depression in the National Institute of Mental Health Treatment of Depression 
Collaboration Research Program (Elkin et al., 1985; Elkin et al., 1989). 
The CSPRS has three subscales measuring adherence to CBT, IPT and clinical 
management and two therapy non-specific subscales for facilitative conditions and explicit 
directiveness. Interrater reliabilities were low but acceptable for the facilitative conditions 
subscale (random effects ICC .47, fixed effects ICC .58) and acceptable to excellent for all 
other subscales, ranging from .58 (random effects) and .73 (fixed effects) on the explicit 
directiveness subscale to .88 (random effects) and .92 (fixed effects) on the CBT subscale 
(Hill et al., 1992). Internal consistency was acceptable for all but the explicit directiveness 
subscale, which had a low Cronbach’s alpha of .50. Greater therapy specific behaviours 
were exhibited by therapists in their respective modalities, than in the other modalities. 
Clinical management therapists mostly used techniques from their own modality, while 
CBT and IPT therapists shared some from each other’s approach, but few from clinical 
management.  
A modified form of the CSPRS was used by McIntosh et al. (2005) to investigate 
adherence to IPT, CBT and specialist supportive clinical management (SSCM) in the 
treatment of anorexia nervosa. This modified form of the CSPRS by McIntosh et al. was 
used to rate audio recordings of psychotherapy sessions for anorexia nervosa, and included 
subscales for IPT, CBT, specialist supportive clinical management (SSCM) and a therapy 
non-specific subscale comprising 18 generic items. Those randomised to IPT had higher 
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adherence scores on the IPT subscale than those randomised to CBT or SSCM, those 
randomised to CBT had higher adherence scores on the CBT subscale than those 
randomised to IPT or SSCM, and those randomised to SSCM had higher adherence scores 
on the SSCM  subscale than those randomised to CBT and IPT. No difference was found 
among the three therapies on the non-specific subscale.  
Another modified form of the CSPRS – the Strong Without Anorexia Nervosa - 
Psychotherapy Rating Scale (SWAN-PRS) was used by Andony et al. (2015) to rate 
therapist adherence to CBT-E, Maudsley Anorexia Nervosa Treatment for Adults 
(MANTRA) and SSCM. Mean subscale scores were calculated for each session, the 
highest score for each session rated was used to determine treatment classification. For 
example if a therapy session received the highest score on the CBT-E subscale, then that 
session would be classified as a CBT-E session. Eighty-six percent of the total pool of 
rated sessions were classified correctly, ninety percent of CBT-E sessions, 81.2% of 
MANTRA sessions and 85.7% of SSCM sessions.  
 
Methodology and results in other adherence studies 
 
Scores on scales reflecting non-specific elements of therapy such as therapeutic 
alliance and aspects of the therapeutic relationship have been found to be comparable for 
specialist psychotherapies including CBT, IPT, SSCM and MANTRA (Hill et al., 1992; 
McIntosh et al., 2005; Andony et al., 2015) with the exception of a higher non-specific 
score for clients randomised to CBT-E than for those randomised to SSCM or MANTRA 
in Andony et al.’s study.  
In a 2006 study by Huppert et al., 205 participants were randomised to receive CBT 
alone, CBT and placebo, CBT and Imipramine, Imipramine alone, or placebo alone. 
Anxiety levels were rated using the PDSS and ASI. Adherence was rated using an 
instrument developed for the study, in which 7-15 items were rated on a 1-7 Likert type 
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scale for each therapy session. These ratings were then summed to derive an average score 
for each session. Therapists also rated participant motivation as part of a questionnaire at 
the end of the second therapy session. Adherence was found to be high, with little 
variation.  
Panic disorder and therapist adherence were studied by Zickgraf et al. (2016). 
Thirty-eight participants received panic control therapy, a type of CBT. Adherence  in the 
sixth session was rated using a scale developed specifically for the study. This was a Likert 
type scale from 1-7, used to rate adherence to five specific interventions and homework. 
Adherence was found to be generally high, but was influenced by interpersonal variables. 
Early alliance was measured using the Working Alliance Inventory – Short Form (Tracey 
& Kokotovic, 1989), and was predictive of adherence, but this was not significant when 
Axis II (DSM-IV; American Psychiatric Association, 2000) personality disorder traits were 
controlled for. When participant resistance was higher, therapist adherence was found to be 
lower.  
Brauhardt et al. (2014) examined adherence to CBT in recordings from 87 people 
with binge-eating disorder (BED). Adherence was assessed using the Adherence Control 
Form (ACF) which was developed to assess therapist adherence to CBT. The ACF consists 
of 10 items rated  0 = non adherent, 1 = partly adherent,  or 2 = adherent. The mean 
adherence score was then derived for each session.  High levels of adherence (classified as 
a mean of greater than 1.5) were found. Significant variability in adherence was found 
between, but not within therapists.  
Puls et al. (2018) also used the ACF to assess adherence to CBT in the treatment of 
64 adolescents with BED. Lower therapist adherence was found to be predicted by higher 
client treatment expectations, but not eating disorder psychopathology or depressive 
symptoms. Adherence was found to be positively associated with therapist/client alliance, 
but alliance was not associated with client treatment expectations, eating disorder 
psychopathology or depressive symptoms. 
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Sinai et al. (2012) studied adherence to IPT and supportive therapy for social 
anxiety disorder. They rated 133 recorded sessions from 53 participants using the CSPRS 
and Liebowitz Social Anxiety Scale. Interrater reliabilities were determined, using 
intraclass correlations, to be good or excellent. Significantly higher adherence scores 
overall were found on the IPT subscale than on the supportive therapy subscale for 
sessions of participants randomised to IPT, and significantly higher adherence scores 
overall were found on the supportive therapy subscale than the IPT subscale for sessions of 
participants randomised to supportive therapy. While there was a significant difference in 
adherence levels between the assigned and competing modalities, both frequently used 
techniques from the other modality. There was no difference in the middle phase between 
the two treatment groups on the IPT subscale.  
 Amole et al. (2016) conducted a study on adherence to IPT and brief supportive 
therapy (BSP). Adherence was measured using the CSPRS-Form 6 (Evans et al., 1984). 
Therapists were found to provide higher levels of IPT specific techniques for depression in 
the IPT treatment group and higher levels of BSP-specific techniques for depression in the 
BSP treatment group. It has been suggested that therapists may use less specific techniques 
as clients improve over time (Amole et al., 2016).  
Adherence over phase of therapy 
Therapist adherence has been found to change over the course of treatment. 
Adherence was found to decrease over time in CBT-E for bulimia nervosa in Folke et al.’s 
(2017) study. Adherence was rated using the Cognitive-Behavioural Therapy Treatment 
Protocol Adherence Scale, on which items were rated from 1-7. A decrease of 
approximately 0.23 units per ten sessions (23%) was found, indicating that adherence to 
treatment protocol decreased over time (Folke et al., 2017).  
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Lange et al. (2019) investigated parental perceptions of therapist adherence in 848 
families receiving multisystemic therapy (MST) for antisocial adolescent behaviour. 
Adherence increased sharply during the earliest months of treatment with MST for 
antisocial adolescent behaviour and then stabilised. The sharper increase was associated 
with lower police contact and out of home placement immediately post-treatment, but not 
at the 18 month follow-up.  
Brauhardt et al. (2014) measured therapist adherence to CBT for binge eating 
disorder using the ACF. Therapist adherence was not predicted by therapist or client 
characteristics. Adherence was found to vary between therapists, but not within. Adherence 
was not found to vary across phase of therapy.  
Adherence over phases of CBT, IPT and SSCM for anorexia nervosa was 
investigated by McIntosh et al. (2016). Adherence was rated over early, middle and late 
phases, using a modified form of the CSPRS, the CSPRS-AN. No significant therapy by 
phase interaction was found for the IPT subscale. Therapist adherence to both CBT and 
SSCM were rated significantly higher in the middle phase, than in the early and late phases 
on the CBT subscale, with those randomised to CBT rating higher than those randomised 
to SSCM. Adherence to SSCM was significantly higher in the middle phase, than in the 
early and late phases on the SSCM subscale.  
The variation of findings in previous research (Sinai et al., 2012; Brauhardt et al., 
2014; McIntosh et al., 2016; Folke et al., 2017; Lange et al., 2019) of adherence over phase 
suggests that different psychotherapies may be implemented differently, with the extent to 
which therapists adhere to specific treatment modalities varying.  
Comparison of Cognitive Therapies Study 
Carter et al. (2013) conducted a randomised, controlled trial to investigate the 
viability of schema therapy as an alternative to cognitive behavioural therapy for 
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depression. In Carter et al.’s study, schema therapy and cognitive behavioural therapy 
produced comparable outcomes, with 34% of schema therapy participants and 28% of 
cognitive behavioural therapy participants in remission at the end of weekly sessions, and 
50% of schema therapy participants and 40% of cognitive behavioural therapy participants 
in remission at the end of monthly sessions. Thirty-four percent of schema therapy 
participants and 38% of cognitive behavioural therapy participants met recovery criteria by 
the end of weekly sessions, and 56% of schema therapy participants and 50% of cognitive 
behavioural therapy participants met recovery criteria by the end of monthly sessions. 
Importance of proposed research 
The current study will build on Carter et al.’s (2013) research by investigating 
therapist adherence to CBT and schema therapy protocols. The current study will also 
investigate therapist adherence to CBT and schema therapy protocols over early, middle, 
and late phase sessions. A greater understanding is required of how and when therapists 
adhere to prescribed treatment modalities and factors which may cause adherence 
variation.  
While it is currently understood that therapies such as CBT and schema therapy are 
effective in treating mental illnesses such as depression, there is less clarity as to what 
makes these therapies successful or unsuccessful. If high adherence is not maintained, it is 
difficult to determine if the particular therapy being implemented is responsible for the 
success or failure of therapy, or if another variable is impacting this outcome, therefore 
maintaining high adherence is essential for determining experimental validity.  
Carter et al.’s (2013) research determined that CBT and schema therapy produced 
comparable outcomes in treating depression. The current study aims to build on this by 
examining therapist adherence scores on the CBT, schema therapy and non-specific 
(facilitative conditions and explicit directiveness) subscales of the CSPRS-CCT for CBT 
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and schema therapy sessions. The current study will use audio recordings of therapy 
sessions from Carter et al.’s study to determine whether CBT and schema therapy for 
depression can be differentiated using the modified form of the CSPRS and by examining 
how these adherence scores vary over treatment phase.  
Some existing research investigates therapist adherence to various therapies for 
both depression and other psychological difficulties, such as anxiety disorders (Huppert et 
al., 2006; Sinai et al., 2012; Zickgraf et al., 2016), borderline personality disorder 
(Goldman & Gregory, 2009), anorexia nervosa (McIntosh et al., 2005; Andony et al, 2015; 
McIntosh et al, 2016), bulimia nervosa (Folk et al., 2017), binge eating disorder (Brauhardt 
et al., 2014; Puls et al., 2018), adolescent antisocial behaviour (Chapman & Schoenwald, 
2011; Lange et al., 2017, 2019) and substance abuse (Hogue et al., 2008; Martino et al., 
2008). Currently no research is known to have investigated therapist adherence to CBT and 
schema therapy for depression. A number of studies (Sinai et al., 2012; Brauhardt et al., 
2014; McIntosh et al., 2016; Folke et al., 2017; Lange et al., 2019) have investigated how 
adherence varies over time and phase of therapy, however none have investigated changes 
over phase for either CBT or schema therapy in the treatment of depression, as in the 
present study. 
Research questions 
The main research questions for the current study are: 
1. How does therapist adherence vary on the CSPRS-CCT subscales for CBT and 
schema therapy? 
2. Does therapist adherence to CBT and schema therapy modalities change over 
therapy phase? 
3. How consistent are raters in rating CBT and schema therapy sessions using the 
CSPRS-CCT in the current study? 
 14 
Objectives 
There are three objectives of this study 
1. To investigate therapist adherence to cognitive behavioural therapy and schema 
therapy protocols using the CSPRS-CCT.  
2. To assess adherence over early, middle, and late phase sessions for both cognitive 
behavioural therapy and schema therapy protocols using the CSPRS-CCT.  








3. Scores on the facilitative conditions and explicit directiveness subscales will not 
differ across therapy type. 
4. Adherence to all subscales will be rated higher in the early to middle phases of 
treatment and will stabilise or decrease in the later stage in therapy, for participants 




Participants were 99 adults (females n = 69, males n = 30) who were part of Carter 
et al.’s (2013) randomised controlled trial comparing schema therapy and cognitive 
behavioural therapy for the treatment of depression. Participants were over the age of 18, 
with major depressive disorder as their principle current diagnosis. Participants attended 
weekly therapy sessions for six months, followed by monthly sessions for six months, at 
the Department of Psychological Medicine, University of Otago, Christchurch, in an 
outpatient clinical research unit. Participants were referred by a mental health service or 
general practitioner, or by self-referral.  
Exclusion criteria for the trial were a history of mania or schizophrenia, current 
severe drug or alcohol dependence, major physical illness which could interfere with 
treatment, treatment with cognitive behavioural therapy or schema therapy in the past year 
and the use of any centrally acting drug in the previous fortnight (excluding the oral 
contraceptive pill or occasional sleeping tablet use). 
 
Protocol 
Ethics approval was obtained for the original study from the Canterbury Ethics 
Committee in 2003 (Appendix B). An exemption was obtained from the University of 
Canterbury Human Ethics Committee (Appendix A) for use of the recordings in the 
present study as this had been approved in an earlier publication. 
Consultation occurred with Māori iwi for the original clinical trial and 
documentation of this can be viewed in Appendix C. It was assessed that Māori cultural 




Severity of participants’ depressive symptoms was assessed using the Hamilton 
Depression Rating Scale (HDRS; Hamilton, 1960), Montgomery Asberg Depression 
Rating Scale (MADRS; Montgomery & Asberg 1979), Beck Depression Inventory (BDI-
II; Beck, Steer, & Brown, 1996) and the Global Assessment of Functioning (GAF; Axis V 
of DSM-IV American Psychiatric Association, 2000). The MADRS, GAF and HDRS are 
clinician rated measures. The HDRS is rated on 17 items, eight of which use a five point 
scale (from 0 = absent to 4 = very severe) and nine of which use a three point scale (0 = 
absent, 1 = doubtful/mild, 2 = clearly present). A total score of 0-7 indicates normal mood, 
8-13 mild depression, 14-18 moderate, 19-22 severe and above 23 indicates very severe 
depression (Hamilton, 1960).   
The MADRS contains 10 items and is coded on a 0-6 scale. A total score of 0-6 
indicates normal mood/recovered, 7-19 mild depression, 20-34 moderate and 35-60 severe 
depression (Snaith et al., 1986).  
The BDI-II is a self-report questionnaire containing 21 items, ranked on a four-
point (0-3) scale. A total score of 0-13 indicates minimal depression, 14–19 mild, 20–28 
moderate and 29–63 indicates severe depression (Beck et al., 1996).  
The GAF, Axis V of the fourth edition of the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-IV-TR) measures the social, occupational and psychological 
functioning of an individual (American Psychiatric Association, 2000). The scale ranges 
from 1-100, with the lowest score range being 1-10 “persistent danger of severely hurting 
self or others (e.g., recurrent violence) OR persistent inability to maintain minimal 
personal hygiene OR serious suicidal act with clear expectation of death” and the highest 
being 91-100 “superior functioning in a wide range of activities, life’s problems never 
seem to get out of hand, is sought out by others because of his/her many positive qualities. 
No symptoms.” (American Psychiatric Association, 2000, p. 34). 
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A modified form of the Collaborative Study Psychotherapy Rating Scale (CSPRS) 
(Evans et al., 1984; Hill et al., 1992) was used to rate adherence to treatment modalities. 
The original CSPRS was designed to rate audio recordings of cognitive behavioural 
therapy, interpersonal psychotherapy, and clinical management with Imipramine or tablet 
placebo for depression (Hill et al., 1992). The form used in the current study was a 
modification of the CSPRS – Form 6 (Evans et al., 1984) and the CSPRS – Binge Eating 
Form (McIntosh et al., 2014). The CSPRS modified for the current study (CSPRS-CCT) 
incorporated items from the original CSPRS scale, and items from the CSPRS-BE which 
included a schema therapy subscale (McIntosh et al., 2014).  
The CSPRS-CCT (Appendix D and Appendix E) comprises 78 items, with two 
subscales measuring adherence to CBT and schema therapy techniques. The CBT subscale 
contains 39 items and the schema therapy subscale contains 28 items. The remaining 12 
items make up two therapy non-specific subscales – facilitative conditions and explicit 
directiveness. Facilitative conditions and explicit directiveness contain general items for 
measuring aspects of therapy that are not specific to a particular therapy type and are a 
measure of the working alliance between therapist and client. These would be expected to 
occur consistently across therapies. Carl Rogers first suggested facilitative conditions in 
1951 during the development of the person-centred approach. The facilitative conditions 
subscale contains eight items, and the explicit directiveness subscale contains four. 
Between the CBT and schema therapy subscales, seven items overlapped. These are items 
common to both CBT and schema therapy, such as education about depression, negotiating 
therapy content and explanation for the therapist’s direction. A visual representation of the 












Raters were trained over three stages: Stage one involved didactic training, which 
included teaching about the therapies and rating instruments. Stage two was group rating of 
sessions with trainers. In stage three, sessions were independently rated and then reviewed 
with trainers. Co-rating occurred until raters’ scores on CSPRS-CCT items were within 
one point of trainers’ ratings. Weekly group review of co-rated sessions occurred 
throughout rating to maintain consistency among raters. Raters were unaware of the 
therapy the client was randomised to receive. 
CBT items (31) Schema therapy 
items (21)










subscale (4)  
items 
Therapy non-specific subscales 
Figure 1.  Diagram displaying subscales and items for the CSPRS-CCT. 
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Procedure 
Three therapy sessions were randomly selected for each of the 99 participants, one 
from each of early (sessions one to five), middle, and late (last five sessions) phases of 
treatment. The first and last sessions were excluded from rating due to their idiosyncratic 
nature. Selected sessions were rated using the CSPRS-CCT to determine therapist 
adherence. Complete therapy sessions were listened to, after which the CSPRS-CCT rating 
scale was completed. Sixty-four sessions (approximately 20%) were randomly selected to 
be co-rated by a second independent rater to assess interrater reliability. Raters were 
postgraduate psychology students, clinical psychologists and clinical psychology graduate 
students.  
Data analysis  
Data analyses were conducted using IBM Statistical Package for the Social 
Sciences Version 25 (SPSS; IBM Corporation, 2016).  
Ten percent of entered data were checked for accuracy. Data were examined for 
normality by visual examination of the distributions, and using the Shapiro-Wilk test of 
normality.  
Adherence for the two treatment groups was examined using independent samples 
t-tests, with therapy type (CBT and schema therapy) as the categorical independent 
variable, and adherence to therapy subscale (schema therapy, CBT, facilitative conditions 
and explicit directiveness) as the continuous dependent variables.  
Adherence levels over the course of treatment were compared using repeated 
measures analyses of variance (ANOVA), with treatment phase (early, middle and late) as 
the categorical independent variable, and adherence to therapy subscale (schema therapy, 
CBT, facilitative conditions and explicit directiveness) as continuous dependent variables.  
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Mixed between-within subjects analyses of variance (ANOVA) were used to 
compare adherence levels over the course of treatment by therapy type (CBT and schema 
therapy), with therapy type as the categorical independent between-subjects variable, phase 
of therapy (early, middle and late) as the repeated measures variable, and the CSPRS-CCT 
subscales (schema therapy, CBT, facilitative conditions and explicit directiveness) as 
continuous dependent variables. 
Interrater reliability and internal consistency  
Intraclass correlations (ICCs) and coefficients of variation were used to determine 
interrater reliability. ICCs are one of the most common statistics reported when examining 
interrater reliability in ordinal, ratio or interval data (Hallgren, 2012), while coefficients of 
variation are more reliable measures when variability is low among a set of ratings. 
Interrater reliabilities were examined for the pairs of dual rated sessions, with both 
intraclass correlations and coefficients of variation calculated for each of the CSPRS-CCT 
subscales. Random effects two-way models of absolute agreement intraclass correlation 
coefficients were calculated (Shrout & Fleiss, 1979).  
Cronbach’s alpha was used as a measure of internal consistency for CSPRS-CCT 
subscales. Internal consistency is a type of scale reliability, the degree to which a scale 
consistently measures a construct. According to Tavakol and Dennick (2011), Cronbach’s 











Data were found to be non-normally distributed for all CSPRS-CCT subscales 
except the facilitative conditions subscale. Transformation was attempted, but the data 
remained non-normal. Due to the large sample size (greater than 30 participants) 
parametric tests were used for all analyses (Pallant, 2013). Fagerland (2012) studied the 
use of t-tests and their non-parametric equivalent, the Wilcoxon-Mann-Whitney test (also 
known as the Mann-Whitney U test) and concluded that non-parametric tests are preferable 
with smaller sample sizes, while t-tests are preferable for larger samples, even with heavily 
skewed data. Blanca, Alarcón et al., (2017) found that the F-test, used in repeated 
measures analysis of variance, was robust even with severe deviation from normality 
across various sample sizes in controlling type I errors (rejection of a true null hypothesis). 
A non-parametric version of a mixed between-within subjects ANOVA also does not exist. 
Due to these factors, parametric tests were used, despite the non-normality of distributions. 
Table 1 displays demographic data for the sample. Nearly 70% were female, with 
the mean age being 38.5 years. Most participants (84.8%) identified as New Zealand 
European, 4% as New Zealand Māori, 8.1% as non-New Zealand European, and 3% as 
other (Japanese, Egyptian and Samoan). Over half (51.5%) were currently married. 
Table 2 shows that the average age at first onset of major depression was 22 years 
for the sample. A single episode of depression had been experienced by a quarter of the 
sample, with two-thirds having experienced recurrent episodes. Ten percent of the sample 





Table 1  








Depression History of Sample (n = 99)
 Total sample 
n/x         %/sd 
Female    69.0  69.7 
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Married 51  51.5 
       Total sample 
n/x   %/sd 
Depression age at first onset 22.0 11.5 
Number of depressive episodes  









Current depression severity  
Mild 
Moderate 











Table 3 shows the comorbid and general psychopathology of participants prior to 
beginning treatment. Generalised anxiety disorder (GAD) was the most common comorbid 
anxiety disorder, with 35.4% of the sample having current GAD. Social phobia and panic 
disorder were also highly comorbid, with 29.3% of the sample having current social phobia 
and 31.3% at some point in their life. Fifteen percent of the sample had current panic 
disorder and 29.3% at some point in their life. Bulimia nervosa was the most common 
eating disorder over the lifetime of participants at 9.1%, and binge eating disorder was the 
most common current eating disorder at 4%. Eight percent had bipolar II disorder and over 
one third had been diagnosed with some form of personality disorder. The mean score on 
the HDRS was 16.3, 23.2 on the MADRS, and 26.4 on the BDI-II, all indicating moderate 
depression (Hamilton, 1960; Snaith et al., 1986; Jackson-Koku, 2016). The mean GAF 
score was 55.2, indicating moderate symptoms, or moderate difficulty in social and 
occupational functioning (American Psychiatric Association, 2000). A previous suicide 
attempt was reported by 26.3% of the sample, and previous self-harm by 25.3%. Current 
alcohol abuse or dependence was reported by 13.1% of participants and by 35.4% of 
participants at some time in their life. Current drug abuse or dependence was reported by 
3% of participants and at some time in their life by 18.2% of participants. 
Table 4 displays means, standard deviations and statistics comparing the two 
therapy groups on each of the CSPRS-CCT subscales, CBT, schema therapy, facilitative 
conditions and explicit directiveness. For the CBT subscale those randomised to CBT 
scored significantly higher than those randomised to schema therapy (t = -11.28, p < .001, 
eta squared = .29). For the schema therapy subscale those randomised to schema therapy 
scored significantly higher than those randomised to CBT (t = 13.46, p < .001, eta squared 
= .46). No difference was found between the two treatment groups on the therapy non-
specific facilitative conditions or explicit directiveness subscales. Participants randomised 
to CBT scored significantly higher on the overlap items (items common to CBT and 
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schema therapy subscales) than those randomised to schema therapy (t = -4.05, p < .001, 
eta squared = .05). Figure 2 represents CSPRS-CCT subscale scores for the two therapy 
groups. 
Table 5 displays means, standard deviations and results of statistical analyses for  
each of the CSPRS-CCT subscales by phase of therapy and therapy group. A therapy by 
phase interaction was found for the CBT subscale (F = 6.73, p = .002, partial eta squared = 
.14). The effect size of .14 indicates a large effect size. Figure 3 shows this interaction 
graphically. Scores on the CBT subscale are consistently lower for the schema therapy 
group than for the CBT group over the three phases of therapy, with the schema therapy 
group’s scores increasing slightly over the three phases of therapy, whereas scores for the 
CBT group decrease over therapy, with the highest mean score in phase one, intermediate 
in phase two, and lowest in phase three. 
A therapy by phase interaction approached significance for the schema therapy 
subscale (F = 3.02, p = .05, partial eta squared = .07). Scores on the schema therapy 
subscale for the CBT group remain consistent over the phases and are lower than for the 
schema therapy group over the three phases of therapy. Schema therapy subscale scores for 
the schema therapy group are slightly lower in phase one than in phases two and three 
which are stable. 
No therapy by phase interaction was found for the therapy non-specific subscales, 
facilitative conditions (F = .07, p = .93, partial eta squared = .002) or explicit directiveness 
(F = .82, p = .44, partial eta squared = .02), or for the overlap items (F = .95, p = .39, 
partial eta squared = .02). 
Table 6 displays means, standard deviations and statistics for each of the CSPRS-
CCT subscales by phase of therapy for the total sample. A significant difference among 
phases was found for the facilitative conditions subscale (F = 16.20, p < .001, partial eta 
squared = .28), with an effect size of .28 indicating a large effect size. Post-hoc tests 
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indicated phase 3 was significantly higher than both phases 1 (t = -.38, p < .001) and 2 (t = 
-.23, p = .001), but no difference was found between phases 1 and 2 (t = -.15 p > .05). This 
difference among phases is shown visually in Figure 4. No analysis of phase was 
conducted for the CBT subscale, due to the presence of a therapy by phase interaction for 
this subscale, as reported in Table 5 and illustrated in Figure 3. No significant differences 
among phases were found for the other CSPRS-CCT subscales. 
Interrater reliability was measured in the present study using both intraclass 
correlations and coefficients of variation. Koo and Li (2016) have reported that ICC values 
less than .5 indicate poor interrater reliability, values between .5 and .75 moderate, 
between .75 and .9 good, and greater than .9 excellent reliability. As seen in Table 7 values 
in the present study indicate good reliability for the CBT subscale (.77), schema therapy 
subscale (.86) and poor reliability for the facilitative conditions (.44) and explicit 
directiveness (.09) subscales.  
Coefficients of variation for the CSPRS-CCT are all low, ranging from 6.9% 
(facilitative conditions subscale) to 13.4% (explicit directiveness subscale), indicating 
minimal variation between raters on each of the subscales, with the highest average 
variation being in the explicit directiveness subscale. 
Cronbach’s alpha was calculated to measure the internal consistency of the CSPRS-
CCT subscales. Internal consistency refers to how closely related each of the items are in 
each of the subscales. An alpha value of .7 - .95 (Tavakol & Dennick, 2011) is deemed 
acceptable interrelatedness, although anything over .90 may be considered too high 





Comorbid Psychopathology, General Psychopathology, Self-Harm, Suicide Attempts, and 
Alcohol and Drug Abuse and Dependence Pre-Treatment of the Sample of 99 Participants.
 n/x %/sd 
Comorbid psychopathology  
Anxiety disorder   
Generalised anxiety disorder – past month 
Panic disorder – past month 
                        – lifetime  
Agoraphobia without panic disorder – past month 
                                                           – lifetime  
Social phobia – past month 
                       – lifetime  
Specific phobia – past month 
                          – lifetime  
Obsessive compulsive disorder – past month 
                                                   – lifetime  
Post-traumatic stress disorder – past month 




  1 





  2 
















Bipolar II – past month   
                 – lifetime   
  8 
  8 
  8.1 
  8.1 
Eating disorder  
Anorexia nervosa – past month 
                              – lifetime 
Bulimia nervosa – past month 
                           – lifetime 
Binge eating disorder – past month  
                                    – lifetime 
  0  
  1 
  3 
  9 
  4 







Personality disorder diagnosis (any) 35 35.4 
General psychopathology  
Hamilton Depression Rating Scale (17 item)    16.3 5.3 
Montgomery Asberg Depression Rating Scale   23.2 6.5 
Beck Depression Inventory-II   26.4 9.6 
Global Assessment of Functioning   55.2 9.4 
Other  
Previous self-harm 25 25.3 
Previous suicide attempt 26 26.3 
Alcohol abuse/dependence – past month 13 13.1 
Alcohol abuse/dependence – lifetime  35 35.4 
Other drug abuse/dependence – past month    3 3.0 
Other drug abuse/dependence – lifetime   18 18.2 
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Table 4 
Means, Standard Deviations and Statistics of Collaborative Study Psychotherapy Rating Scale – Comparison of Cognitive Therapies Subscales 
for Participants Randomised to CBT and Schema Therapy. 
 CBT              (n 
= 158) 
Schema therapy 
(n = 155) 
t p Mean 
diff 
95% CI Effect size 
(eta 
squared) m sd m sd 
CBT subscale 2.44 .62 1.80 .36 -11.28 < .001 -.64 [-.76 , -.53] .29 
Schema therapy subscale 1.63 .23 2.23 .51 13.46 < .001 .61 [.52 , .69] .37 
Overlap items (common to schema therapy and 
CBT) 
3.08 .66 2.78 .63 -4.05 < .001 -.30 [-.44 , -.15] .05 
Facilitative conditions subscale 5.02 .55 5.13 .59 1.69 .09 .11 [-.02 , .24] .01 











Figure 2. Mean Collaborative Study Psychotherapy Rating Scale – Comparison of 
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Collaborative Study Psychotherapy Rating Scale – Comparison of Cognitive Therapies Subscale Scores by Phase for Therapy Group 
 













F p Effect size 
(partial eta 
squared) 
CBT subscale 1.75 (.38) 1.80 (.38) 1.84 (.36) 2.64 (.55) 2.48 (.64) 2.27 (.66) 6.73 < .001 .14 
Schema therapy subscale 2.11 (.50) 2.31 (.52) 2.28 (.49) 1.62 (.22) 1.59 (.25) 1.62 (.24) 3.02 .05 .07 
Overlap items (common to CBT 
and schema therapy) 
2.74 (.75) 2.69 (.56) 2.85 (.56) 3.08 (.70) 2.99 (.58) 2.96 (.66) .95 .39 .02 
Facilitative conditions subscale 4.91 (.52) 5.06 (.53) 5.31 (.59) 4.88 (.48) 5.02 (.60) 5.24 (.53) .07 .93 .00 





Figure 3. Mean CBT subscale scores for CBT and schema therapy groups over early, 

























Collaborative Study Psychotherapy Rating Scale – Comparison of Cognitive Therapies Subscale Scores by Phase of Therapy 






F p Effect size (partial 
eta squared) 
Schema therapy subscale 1.87 (.46) 1.96 (.55) 1.96 (.51) 1.75 .18 .04 
Overlap items (common to schema 
therapy and CBT) 
2.91 (.74) 2.84 (.58) 2.90 (.61)    .59 .56 .01 
Facilitative conditions subscale 4.90a (.50) 5.04a (.56) 5.28b (.56) 16.20 < .001 .28 
Explicit directiveness subscale 3.89 (.62) 3.73 (.55) 3.82 (.73)   2.54 .09 .06 
Note: means followed by the same superscript letter are not significantly different. Analysis for CBT subscale not completed due to the presence 
of a therapy x phase interaction for this subscale.
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Table 7  
 Intraclass Correlations and Internal Consistency for the Collaborative Study 



































 Interrater reliability  
Internal consistency - 
Cronbach’s α 
 Intraclass correlation 
coefficient 
Coefficients of variation 
(%) 
CBT subscale  .77 13.2 .85 
Schema therapy subscale .86 10.6 .84 
Facilitative conditions .44    6.9 .73 
Explicit directiveness .09  13.4 .50 
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Discussion 
Aims of the present study were to investigate therapist adherence to cognitive 
behavioural therapy and schema therapy protocols using the CSPRS-CCT; to examine 
adherence over early, middle, and late phase sessions for both cognitive behavioural 
therapy and schema therapy protocols using the CSPRS-CCT; and to assess interrater 
reliability in rating adherence using the CSPRS-CCT.  
In the present study the CBT group scored higher than the schema therapy group 
on the CBT subscale, while the schema therapy group scored higher on the schema 
therapy subscale. Interestingly the CBT group also scored higher on the overlap items. 
A therapy by phase interaction was found for the CBT subscale with adherence to CBT 
decreasing over phase. No other significant interactions were found. Intraclass 
correlation coefficients were all good (Koo & Li, 2016), with the exception of 
coefficients for the facilitative conditions and explicit directiveness subscales. 
Coefficients of variation were all excellent, with the highest being 13.6% for the 
overlap items. Alpha values for all subscales were in the acceptable range of .70 - .90 
(Streiner, 2003; Tavakol & Dennick, 2011) with the exception of the overlap items and 
the explicit directiveness subscale which had alpha values of .41 and .50. 
Three research questions were posed for the present study, the first of which was 
how does therapist adherence vary on the CSPRS-CCT subscales for CBT and schema 
therapy? Based on previous research by Hill et al. (1992), McIntosh et al. (2005) and 
Amole et al. (2016), who found greater use of therapy specific techniques in their 
respective modalities than in other modalities, it was hypothesised that therapy for those 
randomised to CBT would have higher adherence scores on the CBT subscale than for 
those randomised to schema therapy, while therapy for those randomised to schema 
therapy would have higher adherence scores on the schema therapy subscale than for 
those randomised to CBT.  
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As hypothesised, and in line with previous research (Hill et al., 1992; McIntosh 
et al., 2005; Amole et al., 2016), those randomised to CBT scored higher on the CBT 
subscale, while those randomised to schema therapy scored higher on the schema 
therapy subscale. Those randomised to CBT also scored higher on the overlap items. 
CBT begins with an assessment and engagement phase and then focuses on 
identifying and changing underlying automatic thoughts which influence and are 
influenced by feelings and behaviours. Schema therapy, while incorporating elements 
of CBT, also focuses on identifying and challenging maladaptive schemas which have 
developed in early life. The early phase of schema therapy treatment involves 
assessment and education, as does CBT. Client and therapist later move into treatment 
using cognitive strategies such as examining evidence for and against the schema, 
generating healthy responses to schemas and keeping schema diaries; using experiential 
strategies such as imagery and schema dialogues; and through behavioural pattern 
breaking (Young et al., 2003). This means there will be some similarities between the 
therapy modalities, such as education about depression, negotiating therapy content and 
explanation for the therapist’s direction. However while overlap implies that these items 
may occur in both therapies, it does not mean that they would be expected to occur 
equally. In the present study, the CBT group has higher scores on overlap items than the 
schema therapy group. For example, at the beginning of a CBT session an agenda is 
usually created by negotiation between therapist and client (Beck, 2011). This 
negotiation of therapy content may also occur in schema therapy, but may not be as 
explicit as in CBT.  
Adherence scores on the facilitative conditions and explicit directiveness 
subscales were also hypothesised to be similar between therapies. As expected, there 
were no differences between the CBT and schema therapy groups on either facilitative 
conditions or explicit directiveness subscales. This finding is not surprising  as the 
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facilitative conditions and explicit directiveness subscales contain items measuring 
aspects of therapy such as therapist empathy, warmth, guidance and receptive listening, 
which are not specific to a particular therapy type, but are common indicators of good 
alliance between therapist and client and would be expected to occur across all 
therapies.  
Facilitative conditions were first suggested by Carl Rogers in 1951 as part of his 
person centred therapy approach and included congruence, unconditional positive 
regard and empathy. Rogers later expanded this in his 1957 work, suggesting that six 
conditions are needed in therapy to achieve constructive change over time, including 
two people who are in psychological contact, one of which is the client who is 
vulnerable and the other the therapist. The therapist should experience unconditional 
positive regard and be empathic towards the client. Positive regard and empathy should 
be communicated to the client (Rogers, 1957).  
Facilitative conditions were measured in the current study using eight items and 
explicit directiveness (the therapist’s guidance of the session) was measured using four 
items. Both facilitative conditions and explicit directiveness are aspects of the alliance 
between therapist and client, which has been found to be an important predictor of 
outcome in cognitive therapies. The alliance between therapist and client measured over 
multiple sessions was found to be a stronger predictor of outcome than alliance 
measured at only one stage of therapy in research by Crits-Cristoph et al. (2011), while 
Arnow et al. (2013) found that strong alliance early in therapy predicted greater 
symptom reduction in two therapies for depression.  
The second question posed was does therapist adherence to CBT and schema 
therapy modalities change over therapy phase? It was hypothesised, based on research 
by McIntosh et al. (2016), who found that therapist adherence to CBT and SSCM was 
rated significantly higher in the middle phase, Folke et al. (2017) who found that 
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adherence to CBT-E was highest in the earlier phase of therapy and steadily decreased 
over time, and Lange et al. (2019) who found a sharp increase in adherence in the early 
months of treatment with multisystemic therapy followed by stabilisation of adherence, 
that adherence would be rated higher in the early to middle phases of treatment and 
would stabilise or decrease in the later stage of treatment for both CBT and schema 
therapy groups. Amole et al. (2016) have suggested adherence may decrease over phase 
as the client’s symptoms improve and fewer therapeutic techniques are required. Later 
stages of CBT and schema therapy focus less on introducing new psychotherapy 
techniques, instead focusing on practising those already learnt and maintaining progress 
(Beck et al., 1979; Young et al., 2003). 
In the present study a therapy by phase interaction was found for the CBT 
subscale, with adherence to CBT decreasing over phase. The finding of a therapy by 
phase interaction for the CBT subscale is consistent with the above hypothesis and with 
previous research by McIntosh et al. (2016), who found a therapy by phase interaction 
for CBT, although they found that adherence was highest in the middle phase and by 
Folke et al. (2017), who found that adherence to CBT-E decreased over time in the 
treatment of bulimia nervosa. This may be due to the therapist being more likely to 
adhere strictly to CBT modalities in the earlier phase of therapy when the client is 
exhibiting greater depressive symptoms.  
This is not the case for the schema therapy subscale in the present study, as no 
therapy by phase interaction was found. This may indicate that adherence to schema 
therapy modalities differs from adherence to CBT modalities in that adherence remains 
constant across phases of schema therapy, compared to CBT in which adherence has 
been found to decrease over time. In schema therapy, time is spent in early sessions 
identifying maladaptive schemas and modes, and in later sessions is spent challenging 
these maladaptive schemas/modes and building on healthy schemas (Young et al., 
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2003), whereas in CBT, as sessions progress, clients are more able to identify and 
challenge automatic thoughts on their own and sessions in the later phase may focus 
more on maintaining these skills, rather than introducing new CBT techniques. 
For the sample as a whole, a significant phase effect was found for the 
facilitative conditions subscale, with adherence in phases one and two significantly 
lower than in phase three and no difference between phase one and phase two.  The 
facilitative conditions subscale measures alliance between therapist and client. By the 
final phase of therapy the therapist and client have been working together for several 
months and would therefore be expected to have developed a strong working alliance. 
The third question posed was how consistent are raters in rating CBT and 
schema therapy sessions using the CSPRS-CCT in this study? This question was 
assessed by calculating ICCs (Shrout & Fleiss, 1979) and coefficients of variation to 
measure interrater reliability. ICCs are measured on a scale from 0 to 1. Zero represents 
no reliability and 1 represents perfect reliability with no error. According to Koo & Li 
(2016), ICCs above 0.5 represent moderate reliability, above 0.7 good, and above 0.9 
excellent reliability. The coefficient of variation is a unit-free measure of dispersion 
which represents the ratio of the standard deviation to the mean and is thus a simpler 
statistic. A coefficient of variation below 25% represents low levels of dispersion 
around the mean for paired ratings and is considered to indicate high agreement 
between raters.  
ICCs for subscales of the CSPRS-CCT were found to be good, between .70 and 
.90 (Koo & Li, 2016), with the exception of coefficients for the facilitative conditions 
and explicit directiveness subscales. When variability is low in a set of ratings, 
reflecting restricted range or a skewed distribution, intraclass correlations underestimate 
the agreement among pairs of raters. An example of this is given in a scenario discussed 
by Hallgren (2012). In two hypothetical studies of therapist empathy, one study’s 
 38 
sample is from a community clinic and the second study’s sample is drawn from a 
university clinic. Empathy ratings from the community clinic were normally distributed 
and ICCs were high. Empathy ratings from the university clinic where therapists were 
highly trained and closely supervised, were restricted to the upper end of the rating 
scale. This resulted in a skewed distribution and lower ICC values.  
In the current study, the ICCs reflecting poor interrater agreement for the 
facilitative conditions and explicit directiveness subscales are comparable to the 
hypothetical example by Hallgren (2012). All participating therapists were highly 
trained clinical psychologists treating clients in a university clinic as part of a 
randomised controlled trial and would be expected to display high levels of aspects 
measured by these subscales such as warmth, empathy, guidance and receptiveness. 
Low rating variability and skewed distributions are evident in both the facilitative 
conditions and explicit directiveness subscales. For example, for the item warmth, no 
ratings of 1 (not at all) or 2 (very little) and only one rating of 3 was given, whereas 20 
ratings of 4, 132 ratings of  5, 129 ratings of 6 and 45 ratings of 7 (very much) were 
given, resulting in a highly skewed distribution. Intraclass correlation coefficients take 
into account both distribution of the data and interrater agreement, with more heavily 
skewed distributions impacting on calculation of ICCs (Hallgren, 2012; Mehta et al., 
2017). When working with a skewed distribution, coefficients of variation are a more 
appropriate statistic to use to examine interrater agreement. All coefficients of variation 
in the present study were excellent. This indicates the mean variation between raters on 
each of the subscales was low, with the highest being 13.4% for the explicit 
directiveness subscale, all indicating excellent consistency between pairs of raters. 
Internal consistency is a measure of the inter-relatedness of items in a scale. 
Internal consistency was measured for each of the subscales in the present study using 
Cronbach’s alpha. Cronbach’s alpha values were found to be acceptable, indicating a 
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high degree of item inter-relatedness for all of the subscales except the explicit 
directiveness subscale with an alpha value of .50. The low alpha value for the explicit 
directiveness subscale is likely due to the small number of items making up this 
subscale (four items only). Tavakol and Dennick (2011) indicate that a small number of 
items in a test can result in decreased Cronbach’s alpha values.  
Strengths and Limitations 
The present study has a number of strengths. Therapy sessions were randomly 
selected from a large sample of 99 participants, therefore, while data were not normally 
distributed, and were unable to be transformed to approximate a normal distribution, the 
relatively large sample size allowed parametric data analytic methods to be used.  
Full therapy sessions were rated for all participants over the phases of therapy, 
meaning the ratings are a good reflection of therapist adherence throughout entire 
sessions and over time for all participants. Previous studies have examined adherence 
with small sections of sessions (Goldman & Gregory, 2009), a randomly selected group 
of participants from the total study (Huppert et al., 2006), or from only one therapy 
session per participant, often in the early stages of therapy (Barber et al., 1996; Weck et 
al., 2013; Zickgraf et al., 2016). By examining adherence for all participants and from 
entire sessions over different phases of therapy, ratings in the present study are a good 
reflection of adherence throughout the entire therapy process for each participant, rather 
than a snapshot at only one particular point in therapy. 
Sixty-four therapy sessions were randomly selected to be co-rated for interrater 
reliability, with good interrater reliabilities found. Intraclass correlation coefficients 
ranged between moderate and good for CBT and schema therapy subscales but not for 
the non-specific (explicit directiveness and facilitative conditions) subscales. Low 
coefficients of variation were found for all subscales. This is a strength of the present 
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study as good interrater reliability indicates consistency among raters when using the 
CSPRS-CCT.  
Another strength of this study is the greater number of female participants 
(70%). This is reflective of depression rates by sex in the wider New Zealand 
population. In the 2018/2019 New Zealand Health Survey 20.3% of women had been 
diagnosed with depression, compared with 11.0% of men. Women were found to have 
higher rates of depression across all age groups (Ministry of Health, 2019). 
A limitation of the present study is the representation of ethnic minorities. 
Ethnicity in the present study was largely New Zealand European (84.4%) and non-
New Zealand European (8.1%), with 4% Māori. In the 2013 New Zealand census, 74% 
of people identified as being of European descent, 14.9% as Māori, 11.8% as Asian, 
7.4% as Pacific, and 1.2% as Middle Eastern/Latin American/African (Statistics New 
Zealand, 2013). While the present study does include some ethnic minorities, 4% Māori 
and 3% Japanese, Egyptian and Samoan, this is lower than the actual representation of 
these minorities in the New Zealand population as a whole, which may limit the 
generalisability of the present study. Seventy percent of participants had moderate 
depression, meaning there is potential for results to vary if a larger proportion of the 
sample was experiencing mild or severe depression. 
 
Implications  
Adherence to CBT, as shown by scores on the CBT subscale, was found to 
change over phase for the CBT group, with adherence highest in the early phase and 
lower over middle and late phases. This finding is in line with the hypothesis that 
adherence to therapy modalities would be initially higher and then decrease as therapy 
progressed and is consistent with findings from previous research. For example 
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McIntosh et al., (2016) found that adherence to CBT and SSCM for anorexia nervosa 
was highest in the middle phase, Folke et al. (2017) found that adherence to CBT-E for 
bulimia nervosa decreased over phase and Lange et al. (2019) found that adherence to 
multisystemic therapy for adolescent antisocial behaviour initially increased rapidly and 
then stabilised.  
For the schema therapy subscale, the therapy by phase interaction approached, 
but did not quite reach the level of statistical significance, p < .05, indicating that the 
pattern over the three phases of therapy was somewhat different for the two treatment 
groups. When examining the means for the schema therapy group adherence was found 
to be lower in the first phase, rose in the middle phase and then plateaued over the final 
phase of therapy. For those randomised to CBT, adherence to the schema therapy 
subscale revealed substantially lower mean scores, which were relatively stable over all 
phases. Not surprisingly, due to the combining of these two samples, examination of the 
main effect of phase on the schema therapy subscale for the total sample revealed no 
change in adherence to schema therapy over the phases of therapy. This is unsurprising 
as the early phase of schema therapy is spent introducing the client to treatment and 
assessing which schemas have developed in early life, while the middle and late phase 
focus on using experiential strategies and behavioural pattern breaking (Young et al., 
2003). 
This does not support the hypothesis that adherence to therapy modalities would 
be highest in the early phase and then decrease over the middle to late phase. However 
research by Brauhardt et al. (2014) did not find variation in adherence over treatment 
phase in CBT for binge eating disorder and McIntosh et al. (2016) found no therapy by 
phase interaction in adherence to IPT for anorexia nervosa. The findings of no variation 
in adherence over phase for Brauhardt et al. (2014) and McIntosh et al. (2016) are 
supported by the findings for schema therapy adherence over phase in the present study. 
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 These findings indicate there may be differences in delivery of different 
therapies, for example greater adherence to CBT modalities may be more important in 
the earlier phase of CBT, whereas having consistent adherence overtime may be more 
important when delivering schema therapy. 
Future directions 
The effect of phase on outcome needs to be studied. Previous studies have found 
that adherence may vary across phase (McIntosh et al., 2016; Folke et al., 2017; and 
Lange, et al., 2018), however these changes over phase appear to vary between therapy 
type, with a study by Brauhardt et al. (2014) finding no variation of adherence over 
phase in their study of CBT for binge-eating disorder. In the present study, variability 
over phase was found for CBT but not for schema therapy. Higher adherence was found 
in the early phase which decreased in middle and late phases. Research needs to be 
conducted to determine whether it is important to have high adherence in all phases, or 
whether one phase is more important than the others. This was not able to be 
determined in this study as adherence was relatively high for all sessions.  
Conclusion 
Understanding adherence both provides insight into how therapies are delivered 
and determines that therapies are being delivered correctly. The present study found 
that CBT and schema therapy are distinguishable using the CSPRS-CCT to rate 
therapist adherence to treatment modalities. This indicates that the CSPRS-CCT is a 
reliable way to distinguish between the two therapies.  
The present study also determined that there were differences in adherence 
levels over therapy phase for CBT on the CBT subscale, with adherence levels being 
highest in the early phase, and then decreasing over middle and late phases. The therapy 
 43 
by phase interaction for the schema therapy subscale approached, but did not reach 
significance.  
The CSPRS-CCT was found to have good reliability in measuring adherence to 
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III Collaborative Study Psychotherapy Rating Scale – Adapted for the 
Comparison of Cognitive Therapies Study (CSPRS-CCT) 
  
Subscales and Items: 
Overlap items 
CBT Subscale 
Schema Therapy Subscale 
Non-specific subscale 
• Facilitative conditions 
• Explicit directiveness 
 
CBT and Schema therapy overlap items 
1. Education about depression 
2. Addressing need for change 
4. Encourage independence 
5. Advice giving 
28. Review since last session 
35. Explanation for therapist’s direction 
42. Negotiating therapy content 
 
CBT Items 
9. Cognitive behavioural therapy rationale 
11. Searching for alternative explanations 
14. Recording thoughts 
15. Scheduling/structuring activities 
23. Self-monitoring 
25. Practicing rational responses 
26. Adaptive/functional value of beliefs 
27. Distancing of beliefs 
29. Specific Examples 
32. Increasing pleasure and mastery 
34. Exploring personal meaning 
36. Exploring underlying assumptions 
38. Homework assigned 
40. Relate improvement to cognitive and behavioural change 
43. Relationship of thoughts and feelings 
46. Collaboration 
49. Realistic consequences 
53. Homework reviewed 
54. Setting and following agenda 
57. Planning / practising alternative behaviours 
61. Didactic persuasion 
62. Testing beliefs prospectively 
63. Manipulating behaviour via cues or consequences 
66. Skills training 
71. Summarising 
72. Examine available evidence 
73. Substituting more helpful thoughts 
75. Reporting cognitions 
76. Recognising cognitive errors 
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77. Behavioural experiments 
78. Graded exposure 
 
Schema therapy Items 
3.  Schema link to childhood 
6. Affect link to schema 
7. Test schemas prospectively 
8. Coping styles 
10. Schema/modes education 
13. Schema therapy rationale 
16. Identification of schema/modes 
17. Client feelings in therapy 
18. Therapy link to rest of life 
19. Therapist/client relationship 
22. Experience of affect 
24. Behavioural pattern-breaking 
37. Empathic confrontation 
39. Safe place imagery 
44. Use of experiential techniques 
47. Coping skills 
50. Use of role play 
51. Exploration of childhood 
52. Didactic persuasion re schemas 
55. Schema formulation 
56. Activation of schema/modes/coping styles 
58. Needs education 
64. Link schemas or modes to depressive symptoms or life problems 
65. Use of imagery for assessment 
67. Reality test 
68. Practicing helpful schemas 
70. Reattribution 
74. Reattribution to schema 
 





31. Supportive encouragement  
41. Involvement 
45. Convey expertise 
48. Therapist’s communication style 
59. Formality        
 
Explicit directiveness  
20. Level of verbal activity 
33. Receptive listening      
60. Subtle guidance       
69. Explicit guidance 
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